CELG News and Press, Celgene Corporation From 05/28/19

Approval marks the first chemotherapy-free combination regimen for patients who have relapsed or did not respond to previous treatment Approval based on Phase 3 AUGMENT study, which showed the combination significantly improved median progression-free survival versus rituximab monother...

Empowering Investors To Make Informed Decisions. Seeking Alpha's mission is, " to empower investors to make informed decisions " . Here at Analysts' Corner, we believe demystifying the financial statements of corporations is a good start to the empowering process. Forget arguments on whethe...

This article is part of a series that provides an ongoing analysis of the changes made to Dan Loeb’s 13F stock portfolio on a quarterly basis. It is based on Third Point’s regulatory 13F Form filed on 05/15/2019. Please visit our Tracking Dan Loeb’s Third Point Portfoli...

Merger activity increased last week with three new deals announced, two pending deals closing and one deal terminated. Deal Statistics: New Deals: The acquisition of Isramco (ISRL) by Naphtha Israel Petroleum Corporation for $393.11 million or $121.40 per share in cash. The ...

Recently for those that trade M&A stocks it has been a case of arbageddon. So many current deals have hit potholes in one way or another. Spark Therapeutics ( ONCE ) has filed and then refiled their respective pre-merger notification and report forms to federal regulators an unusually hi...

This article is part of a series that provides an ongoing analysis of the changes made to John Paulson's 13F stock portfolio on a quarterly basis. It is based on Paulson's regulatory 13F Form filed on 05/15/2019. Please visit our Tracking John Paulson's Pau13lson & Company Portfolio ser...

According to Aerpio Pharmaceuticals (ARPO) website, they are a bio pharmaceutical company focused on advancing first-in-class treatments for ocular diseases. Personally, I think the description is far too narrow and base my opinion on both the company's recent strong secondary readouts from ...

Source: BMS Website Empowering Investors To Make Informed Decisions. Seeking Alpha's mission is, " to empower investors to make informed decisions " . Here at Analysts' Corner, we believe demystifying the financial statements of corporations is a good start to the empowering process. ...

Higher short interest is an odd indicator in the market. On one hand, it's a good indicator of sentiment as a high level generally suggests skepticism of the company's outlook, bringing bears to expect eventually lower share prices. It's also a poor indicator because significant levels of shor...

“Brain Bulb” Hot Air Balloon Takes Flight in NYC Area to Elevate Importance of Brain Preservation Celgene Corporation (NASDAQ: CELG) and the Multiple Sclerosis Association of America (MSAA) today announced the launch of a new campaign, MS MindShift: A New View of MS ,...